Xalkori (Crizotinib)

Xalkori (Crizotinib) is an oral prescription medicine used for treating certain types of non-small cell lung cancer. This targeted therapy works by blocking specific proteins that help cancer cells grow. Always consult a healthcare provider for proper use and dosing guidance.

Xalkori (Crizotinib) is prescribed to treat adults with non-small cell lung cancer that has spread to other parts of the body. It targets specific genetic changes in cancer cells, helping to slow or stop tumor growth. Patients often ask, what is Crizotinib used for, and it is primarily indicated for ALK-positive or ROS1-positive NSCLC.

Xalkori (Crizotinib) may help reduce cancer-related symptoms and slow disease progression in eligible patients. Common effects include gastrointestinal discomfort, fatigue, and vision changes. Individual responses vary, and not all users experience the same effects.

Xalkori (Crizotinib) should be taken exactly as prescribed by a healthcare professional. Regular monitoring, including liver function tests, is recommended during treatment. Patients should report any unusual symptoms, such as severe nausea or vision changes, to their doctor promptly.

Crizotinib may interact with other medications, including strong CYP3A inhibitors or inducers, which can affect its effectiveness. Grapefruit products and certain herbal supplements may also interact. Always inform your healthcare provider about all medications and supplements you are taking.